These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
40 related articles for article (PubMed ID: 23873730)
1. Peptide matching between Epstein-Barr virus and human proteins. Capone G; Calabrò M; Lucchese G; Fasano C; Girardi B; Polimeno L; Kanduc D Pathog Dis; 2013 Dec; 69(3):205-12. PubMed ID: 23873730 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the EBNA1 proteins of Epstein-Barr virus and herpesvirus papio in sequence and function. Yates JL; Camiolo SM; Ali S; Ying A Virology; 1996 Aug; 222(1):1-13. PubMed ID: 8806482 [TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of the expression of the Epstein-Barr virus (EBV) anti-apoptotic gene BHRF1 in nasopharyngeal carcinoma and EBV-related lymphoid diseases. Nicholls J; Kremmer E; Meseda CA; Mackett M; Hahn P; Gulley ML; Brink A; Swinnen LJ; Greenspan J; De Souza Y; Grässer F; Sham J; Ng MH; Arrand JR J Med Virol; 2001 Sep; 65(1):105-13. PubMed ID: 11505451 [TBL] [Abstract][Full Text] [Related]
4. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription. Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040 [TBL] [Abstract][Full Text] [Related]
5. Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein-Barr virus-encoded nuclear antigen EBNA I. Sabbatini A; Bombardieri S; Migliorini P Eur J Immunol; 1993 May; 23(5):1146-52. PubMed ID: 8386666 [TBL] [Abstract][Full Text] [Related]
6. Assessment of major histocompatibility complex class I interaction with Epstein-Barr virus and human immunodeficiency virus peptides by elevation of membrane H-2 and HLA in peptide loading-deficient cells. Stuber G; Modrow S; Höglund P; Franksson L; Elvin J; Wolf H; Kärre K; Klein G Eur J Immunol; 1992 Oct; 22(10):2697-703. PubMed ID: 1327802 [TBL] [Abstract][Full Text] [Related]
7. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome. Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005 [TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study. Leong IT; Fernandes BJ; Mock D Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266 [TBL] [Abstract][Full Text] [Related]
9. Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptide. Okugawa K; Itoh T; Kawashima I; Takesako K; Mazda O; Nukaya I; Yano Y; Yamamoto Y; Yamagishi H; Ueda Y Oncol Rep; 2004 Oct; 12(4):725-31. PubMed ID: 15375491 [TBL] [Abstract][Full Text] [Related]
10. Elevated immunoglobulin G antibodies to the proline-rich amino-terminal region of Epstein-Barr virus nuclear antigen-2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sjögren's syndrome patients with pulmonary involvements. Yamazaki M; Kitamura R; Kusano S; Eda H; Sato S; Okawa-Takatsuji M; Aotsuka S; Yanagi K Clin Exp Immunol; 2005 Mar; 139(3):558-68. PubMed ID: 15730403 [TBL] [Abstract][Full Text] [Related]
11. The Epstein-Barr virus nuclear antigen-1 reprograms transcription by mimicry of high mobility group A proteins. Coppotelli G; Mughal N; Callegari S; Sompallae R; Caja L; Luijsterburg MS; Dantuma NP; Moustakas A; Masucci MG Nucleic Acids Res; 2013 Mar; 41(5):2950-62. PubMed ID: 23358825 [TBL] [Abstract][Full Text] [Related]
12. In silico evidence of de novo interactions between ribosomal and Epstein - Barr virus proteins. Sim EU; Talwar SP BMC Mol Cell Biol; 2019 Aug; 20(1):34. PubMed ID: 31416416 [TBL] [Abstract][Full Text] [Related]
13. EBV-Associated Cancer and Autoimmunity: Searching for Therapies. Capone G; Fasano C; Lucchese G; Calabrò M; Kanduc D Vaccines (Basel); 2015 Feb; 3(1):74-89. PubMed ID: 26344947 [TBL] [Abstract][Full Text] [Related]
14. Viral perturbations of host networks reflect disease etiology. Gulbahce N; Yan H; Dricot A; Padi M; Byrdsong D; Franchi R; Lee DS; Rozenblatt-Rosen O; Mar JC; Calderwood MA; Baldwin A; Zhao B; Santhanam B; Braun P; Simonis N; Huh KW; Hellner K; Grace M; Chen A; Rubio R; Marto JA; Christakis NA; Kieff E; Roth FP; Roecklein-Canfield J; Decaprio JA; Cusick ME; Quackenbush J; Hill DE; Münger K; Vidal M; Barabási AL PLoS Comput Biol; 2012; 8(6):e1002531. PubMed ID: 22761553 [TBL] [Abstract][Full Text] [Related]
15. The N-terminal portion of an erythrotropin-like peptide from fetal bovine serum has sequence homology with the LDL-receptor and two proteins of the Epstein-Barr virus. Congote LF Biochem Biophys Res Commun; 1985 Dec; 133(2):404-9. PubMed ID: 3002338 [TBL] [Abstract][Full Text] [Related]
16. Principles of Chemical Biology: From Sexy Fatty Acids and EBV probes to Anti-Acid Antibiotic via Post-Biotics and Host-Microbe Metabolic Complementarity. Cell Chem Biol; 2017 Jun; 24(6):647-648. PubMed ID: 28644951 [TBL] [Abstract][Full Text] [Related]
17. Describing the hexapeptide identity platform between the influenza A H5N1 and Homo sapiens proteomes. Kanduc D Biologics; 2010 Sep; 4():245-61. PubMed ID: 20859452 [TBL] [Abstract][Full Text] [Related]
18. Putative Roles and Therapeutic Potential of the Chaperone System in Amyotrophic Lateral Sclerosis and Multiple Sclerosis. Noori L; Saqagandomabadi V; Di Felice V; David S; Caruso Bavisotto C; Bucchieri F; Cappello F; Conway de Macario E; Macario AJL; Scalia F Cells; 2024 Jan; 13(3):. PubMed ID: 38334609 [TBL] [Abstract][Full Text] [Related]
19. IgG Antibody Responses to Epstein-Barr Virus in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Their Effective Potential for Disease Diagnosis and Pathological Antigenic Mimicry. Fonseca A; Szysz M; Ly HT; Cordeiro C; Sepúlveda N Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38256421 [No Abstract] [Full Text] [Related]
20. Antibody Cross-Reactivity in Auto-Immune Diseases. Trier NH; Houen G Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]